Investment
Features
FeesSafety
Academy
More
Pluang+

Compare REX AI Equity Premium Income ETF (AIPI) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

REX AI Equity Premium Income ETFTrade
Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

REX AI Equity Premium Income ETF vs Neurocrine Biosciences Inc — how do they compare? REX AI Equity Premium Income ETF trades at $37.36, while Neurocrine Biosciences Inc trades at $158.1 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is trading nearer its 52-week high, REX AI Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals.

AIPINBIX
Sector
Income / Options OverlayHealth
52-Week High
$44.93$185.50
52-Week Low
$32.45$123.10
Market Cap
$16.46B
Enterprise Value
$16.48B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About REX AI Equity Premium Income ETF

AIPI provides exposure to leading artificial intelligence firms while seeking to generate monthly income. It uses a covered call strategy to capture premiums from the volatility of AI-related stocks.

Read more on AIPI

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX